Iterum Therapeutics PLC reports results for the quarter ended in March - Earnings Summary

Iterum Therapeutics

13/05/2022 13:27

* Iterum Therapeutics PLC  ITRM.OQ  reported a quarterly
adjusted
loss of 2 cents​​ per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 5 cents
per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Iterum Therapeutics PLC's reported EPS for the quarter was
a
loss of 2 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Iterum Therapeutics PLC shares had fallen by 42.9% this
quarter and lost 48.3% so far this year.
    * The company reported a quarterly loss of $3.5 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 12:27 p.m.  ​All
figures in US dollars unless otherwise stated